Also, Eliquis is the only one that showed stat-sig reduction in all cause mortality compared to warfarin (in ARISTOTLE trial). Pradaxa and Xarelto were both approved with non inferiority and given Eliquis data it should get superiority clam vs warfarin in its AFib label.